Search - tctmd.com

Displaying 241 - 260 of 342

Sort: Relevancy | Date

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Shelley Wood

January 22, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

PFO Closure Registry Confirms Risk of New-Onset A-fib

Yael L. Maxwell

November 09, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Daily News

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

Yael L. Maxwell

November 01, 2018

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Caitlin E. Cox

October 04, 2018

Presentation TCT 2018

DAPT and Anticoagulation Post TAVR: What is the Standard of Care?

Presenter: Martina Kelly Speight, Patricia Keegan

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

Presentation TCT 2018

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Presenter: Anibal A. Damonte

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Daily News

Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’

Todd Neale

July 26, 2018

Presentation The Structural Heart Disease Summit 2018

Post LAA Closure Anticoagulation/Antiplatelet Regimens: Data and Practice

Presenter: Josep Rodés-Cabau

June 22, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

L.A. McKeown

June 12, 2018

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Todd Neale

May 14, 2018

Advertisement

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Complications Following TAVR Are Going Down, US Data Show

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

PFO Closure Registry Confirms Risk of New-Onset A-fib

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

European Guidelines Represent First Intersocietal Position on Percutaneous PFO Closure

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

DAPT and Anticoagulation Post TAVR: What is the Standard of Care?

High Mortality but Durable Results With Valve-in-Valve TAVR

Novel LAA Closure Device Shows Promise in Early Experience

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Experts Give Strong Support for PFO Closure in New ‘Rapid Recommendations’

Post LAA Closure Anticoagulation/Antiplatelet Regimens: Data and Practice

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content